SCM
Silverarc Capital Management’s United Therapeutics UTHR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-16,360
| Closed | -$3.6M | – | 92 |
|
|
2023
Q4 | $3.6M | Sell |
16,360
-15,064
| -48% | -$3.31M | 1.07% | 35 |
|
|
2023
Q3 | $7.1M | Buy |
31,424
+1,395
| +5% | +$315K | 2.15% | 12 |
|
|
2023
Q2 | $6.63M | Buy |
30,029
+11,451
| +62% | +$2.53M | 2.05% | 13 |
|
|
2023
Q1 | $4.16M | Buy |
18,578
+2,530
| +16% | +$567K | 1.72% | 21 |
|
|
2022
Q4 | $4.46M | Buy |
16,048
+5,352
| +50% | +$1.49M | 1.28% | 25 |
|
|
2022
Q3 | $2.24M | Sell |
10,696
-5,531
| -34% | -$1.16M | 0.76% | 36 |
|
|
2022
Q2 | $3.82M | Buy |
16,227
+1,391
| +9% | +$328K | 1.18% | 21 |
|
|
2022
Q1 | $2.66K | Buy |
14,836
+285
| +2% | +$51 | 1.1% | 22 |
|
|
2021
Q4 | $3.14M | Sell |
14,551
-6,638
| -31% | -$1.43M | 1.27% | 25 |
|
|
2021
Q3 | $3.91M | Buy |
21,189
+5,900
| +39% | +$1.09M | 2.21% | 13 |
|
|
2021
Q2 | $2.74K | Buy |
15,289
+9,925
| +185% | +$1.78K | 1.22% | 26 |
|
|
2021
Q1 | $897K | Hold |
5,364
| – | – | 0.49% | 54 |
|
|
2020
Q4 | $814K | Buy |
+5,364
| New | +$814K | 0.47% | 54 |
|